Skip to main content
PNAS Nexus logoLink to PNAS Nexus
. 2023 May 19;2(6):pgad167. doi: 10.1093/pnasnexus/pgad167

Vitamin A deficiency compromises the barrier function of the retinal pigment epithelium

Jean Moon 1, Gao Zhou 2, Eckhard Jankowsky 3,4, Johannes von Lintig 5,✉,b
Editor: Adelia Bovell-Benjamin
PMCID: PMC10235913  PMID: 37275262

Abstract

A major cause for childhood blindness worldwide is attributed to nutritional vitamin A deficiency. Surprisingly, the molecular basis of the ensuing retinal degeneration has not been well defined. Abundant expression of the retinoid transporter STRA6 in the retinal pigment epithelium (RPE) and homeostatic blood levels of retinol-binding protein delay vitamin A deprivation of the mouse eyes. Hence, genetic dissection of STRA6 makes mice susceptible to nutritional manipulation of ocular retinoid status. We performed RNA-seq analyses and complemented the data with tests of visual physiology, ocular morphology, and retinoid biochemistry to compare eyes with different vitamin A status. Mild ocular vitamin A deficiency decreased transcripts of photoreceptor transduction pathway-related genes and increased transcripts of oxidative stress pathways. The response was associated with impaired visual sensitivity and an accumulation of fluorescent debris in the retina. Severe vitamin A deficiency did not only impair visual perception but also decreased transcripts of genes encoding cell adhesion and cellular junction proteins. This response altered cell morphology, resulted in significant changes in transport pathways of small molecules, and compromised the barrier function of the RPE. Together, our analyses characterize the molecular events underlying nutritional blindness in a novel mouse model and indicate that breakdown of the outer blood–retinal barrier contributes to retinal degeneration and photoreceptor cell death in severe vitamin A deficiency.

Keywords: RPE, vitamin A, deficiency, transcriptome, STRA6


Significance Statement.

Perturbed vitamin A metabolism is a characteristic of many ocular disease states. How the eyes adapt to vitamin A status has not been investigated in molecular detail. Applying RNA-seq and employing STRA6-deficient mice enabled us to determine the ocular transcriptome under various vitamin A supply conditions. STRA6-deficient mice displayed various degrees of vitamin A deficiency whereas wild-type mice maintained homeostasis. By combining data about genetic pathways with imaging, physiological, and biochemical analyses, we integrated transcriptome changes to ocular phenotypes. The studies revealed that under conditions of mild vitamin A deficiency, the eyes suffered from impaired visual physiology and stress. Severe deficiency affected epithelia maintenance and proper tight junction regulation, culminating in a breakdown of the outer blood–retina barrier.

Introduction

The importance of vitamin A (all-trans-retinol) for vision has long been known because deficiency of the nutrient can damage the eyes throughout the life cycle (1). Vitamin A is the precursor for the visual chromophore (retinaldehyde) and all-trans-retinoic acid (RA). The 11-cis-diastereomer of retinaldehyde forms a Schiff base linkage with the opsin moieties of cone and rod visual pigments. These G protein–coupled receptors mediate phototransduction, the process by which photons are converted into a nerve signal (2). RA is a hormone-like molecule that regulates gene expression through nuclear receptors (3, 4) that are critical for the cell growth, differentiation, and patterning of the eyes (5).

Vitamin A in the blood is delivered to the eyes, thereby supporting retinoid signaling and chromophore synthesis in the eyes. This transport occurs via two overlapping pathways distributing either dietary vitamin A as retinyl esters (REs) in chylomicrons or stored hepatic vitamin A bound to the retinol-binding protein (holo-RBP4) (6). Cellular uptake of vitamin A from these two transport modes is respectively facilitated by lipoprotein lipase or by the RBP4 receptor STRA6 (stimulated by RA6) (7–9). STRA6 is an integral membrane protein of the basolateral membrane of the retinal pigment epithelium (RPE) (10, 11). The protein facilitates the bidirectional transport of vitamin A into RPE cells from circulating holo-RBP4 in a regulated manner (8, 12, 13).

In humans, mutations in the STRA6 gene cause Matthew–Wood syndrome (MWS) (14–16). MWS is characterized by severe bilateral microphthalmia, often in combination with pulmonary dysplasia, cardiac defects, and diaphragmatic hernia (14). This phenotype is consistent with the pleiotropic roles of RA in embryonic development (17). In contrast, mice deficient for STRA6 or its RBP4 ligand develop eyes and are viable when raised on vitamin A-rich diets (18–20). The eyes of Stra6 knockout mice do not establish a retinoid pool sufficient to support visual pigment synthesis, resulting in loss of photoreceptor function and retinal degeneration. During adolescence, the eyes of this mouse mutant rely on supply via the chylomicron-dependent delivery pathway of dietary vitamin A (19, 21). Therefore, their ocular vitamin A status can be manipulated by dietary intervention (19, 21). This characteristic makes this mouse mutant a unique model to study nutritional blindness which is a widespread ailment in children worldwide (22).

Seminal work by Dowling and Wald showed that vitamin A deficiency (VAD) in rats affects photoreceptor function and eventually results in retinal degeneration (23). They further demonstrated that RA can fulfill most vitamin A-dependent activities except photoreceptor function (24). Accordingly, chromophore-deficient mouse mutants do not exhibit the retinal degeneration phenotype of VAD eyes (25–27). However, it is not well defined how the eyes adapt to changes in vitamin A status and what events are associated with the retinal degeneration phenotype in severe VAD.

Here, we subjected Stra6−/− and wild-type (WT) mice to dietary vitamin A deprivation. By this approach, we induced mild and severe ocular VAD in Stra6−/− mice, as determined by biochemical analysis. Deep sequencing (bulk RNA-seq) analyses revealed the transcriptomes of photoreceptors and RPE under these conditions (28). Based on genotype and diet, we associated the transcriptomes with physiological, histological, and biochemical changes of the eyes. Milder deficiency affected the phototransduction machinery and was associated with an elevated expression of genes involved in oxidative stress pathways. The consequences of severe VAD extended to the structural and functional bases of the outer blood–retina barrier (oBRB). The emerging picture underscores that vitamin A is critical to maintain photoreceptor function and overall visual homeostasis. We identify novel aspects of ocular VAD, specifically the vitamin's role in supporting RPE integrity and function. This role of vitamin A may explain the irreversible retinal degeneration and vision loss in children suffering from prolonged VAD.

Results

Stra6-deficient eyes model ocular VAD

To investigate how the eyes adapt to vitamin A status, we used Stra6 knockout mice (18) which exhibit dysregulated ocular retinoid homeostasis (19–21). All mice were bred and raised on a standard rodent diet rich in vitamin A (15 IU/g) to avoid developmental complications. At the time of weaning, WT and Stra6−/− mice were maintained on a vitamin A sufficient (VAS) or VAD diet, which are custom diets routinely implemented to control vitamin A status in rodents (29). The 4 IU retinol/g existing in the VAS diet is consistent with the recommended vitamin A intake for rodents. Four international units is equivalent to 1.2 mg retinol activity equivalents (RAE) which falls within a range adequate in humans. The VAD diet, a modified AIN-93G diet that is free of vitamin A (0 IU/g), is utilized to restrict vitamin A (29, 30).

In response to dietary restrictions, hepatic RE stores were significantly depleted on a VAD diet irrespective of genotype, suggesting that the vitamin was redistributed from its major storage site to other tissues. On a VAS diet, the levels of RE in the livers of Stra6−/− mice were lower than that of WT counterparts (Fig. 1A). High performance liquid chromatography (HPLC) analysis revealed that all visual cycle intermediates exist in all groups of mice (Fig. 1B). The eyes of WT mice, carrying the fully functional Stra6 allele, were largely unaffected by diet. Ocular retinoid homeostasis was abrogated without STRA6, demonstrated by the significantly reduced concentrations under both dietary conditions. Compared with Stra6−/− mice on a VAD diet, those on a VAS diet possessed 400% higher retinoid content (Fig. 1B and C). These characteristics reveal that the degree of ocular VAD can be manipulated by a controlled diet in Stra6−/− mice (Fig. 1D). With such a system, we can ascribe observed changes in VAD Stra6−/− and VAS Stra6−/− groups as responses to severe and mild VAD states, respectively.

Fig. 1.

Fig. 1.

Characterization of retinoid biochemistry. HPLC was used to determine the retinoid content in the livers (A) and eyes (B, C) isolated from WT and Stra6−/− mice that were maintained on a VAS or VAD diet for a period of 12 weeks. Each group of mice represents varying degrees of ocular VAD (D). RE, retinyl ester; VAD, vitamin A deficient; VAS, vitamin A sufficient; 1, retinyl esters; 2, 11-cis-retinal (syn); 3, all-trans-retinal (syn); 4, 11-cis-retinal (anti); 5, all-trans-retinol; 6, all-trans-retinal (anti). Values presented as mean ± SD. *P < 0.05 between genotypes, within diet; #P < 0.05 VAS vs. VAD, within genotype.

Cone and rod phototransduction were compromised in Stra6−/− mice

The generation and recycling of chromophore occur in the RPE layer (Fig. 2A). While the apical side is adjacent to the photoreceptor outer segments, STRA6 is expressed at the basolateral side of the RPE, facilitating ROL transport from the circulation (8). The RPE tissue acts as a metabolic hub that is an optimal target for assessing the response to varying vitamin A levels. Thus, we collected 40 posterior eye cup tissues (RPE/choroid) to compare changes in the transcriptome between Stra6−/− and WT mice 12 weeks after placement on a VAS or VAD diet. Treatment with dispase improved separation of the eyecup from the retina (Fig. S1). While the expression of Rhodopsin (Rho), albeit significantly lower compared with Retinoid isomerase (Rpe65), indicated cross-contamination in our sample preparation, this allowed us to monitor into the condition of the photoreceptor layer (Fig. 2B).

Fig. 2.

Fig. 2.

RPE–choroid isolation for bulk RNA-seq. Metabolism and cycling of retinoids exist in the RPE layer which is situated in between the retina and circulation (A). The outer eyecup, consisting of the RPE and choroid, was isolated from mice after a 12-week intervention with either a VAS or VAD diet. Rpe65 and Rho gene expression in the outer cup was assessed using qPCR (B). Plot of the first two components of total gene expression data set (C). Volcano plot of significant genes (D) and GO BP ontology terms from the down-regulated (E) and up-regulated (F) gene sets based on comparing Stra6−/− VAS relative to WT VAS samples. n = 5 mice per group. Arr3, arrestin 3; Cnga3, cyclic nucleotide-gated channel alpha 3; Hspa1a, heat shock protein 1A; Hspa1b, heat shock protein 1B; Il6ra, interleukin-6 receptor; Opn1sw, opsin 1, short-wave-sensitive; Pde6h, phosphodiesterase 6H.

Both eyecups from each mouse were pooled together as a single biological replicate (n = 5 mice per group). All analyses were carried out on the data set comprised of 24,411 genes, and genes with low counts were prefiltered prior to running DESeq2. WT and VAS were used as reference levels for the genotype and diet factors, respectively. To gain insights into the similarity across the conditions, we performed principal component analysis (PCA) (Fig. 2C) and noted Stra6−/− groups clustered together away from the WT groups. Differential expression (DE) and pathway analyses were carried out on genes with an adjusted P < 0.05 and a log2 fold change >2 or <−2.

We analyzed differentially expressed transcripts in VAS Stra6−/− samples relative to VAS WT samples. Significantly down-regulated genes included Cnga3, Pde6h, Opn1sw, and Arr3 which are all involved specifically in the cone phototransduction pathway (Fig. 2D). Furthermore, we observed enrichment for gene ontologies (GO) including visual and sensory perception (fold enrichment = 40) (Fig. 2E). Results from full-field electroretinography supported these findings. Photopic responses, mediated by cone cells, were significantly dampened in Stra6−/− mice (Fig. 3A). The pattern was similar in dark-adapted, rod cell-driven scotopic a- and b-wave amplitudes (Fig. 3B and C).

Fig. 3.

Fig. 3.

Assessing retina function and morphology. ERG photopic (A) and scotopic (B, C) responses from Stra6−/− and WT mice (n = 4) on a VAS diet for 12 weeks. Representative OCT (D, F) and SLO (E, G) images. Circles indicate autofluorescent spots. INL, inner nuclear layer; ONL, outer nuclear layer. Values presented as mean ± SD. *P < 0.05, unpaired two-tailed t test.

Mild VAD led to inflammation and stress in the RPE

When we analyzed retina morphology by optical coherence tomography (OCT), we did not notice pronounced changes in thickness of the retina layers of Stra6−/− VAS mice (Figs. 3D and S2). However, scanning laser ophthalmoscope (SLO) images revealed autofluorescent spots in the ventral region of Stra6−/− that were absent in the retina of WT mice (Fig. 3E and G). Such spots have been previously identified as indication of microglia and macrophage infiltrating and clearing apoptotic photoreceptor cells (31–33). The impact on the retina may be associated with stress in the RPE, as suggested by the enrichment of GO terms cellular response to extracellular stimulus (fold enrichment = 6.8) and response to stress (fold enrichment = 1.6) as well as by the higher transcript levels of Hspa1a, Hspa1b, and Angptl4 genes (Fig. 2D and F). Angiopoietin-like proteins are involved in a variety of processes including angiogenesis, vascular permeability, and inflammation, and ANGPTL4 specifically has been implicated in oxidative stress in the RPE (34). Additionally, this was accompanied by the increased expression of Il6ra, encoding the interleukin-6 signal transducer receptor, in VAS Stra6−/− mice.

VAD affects the retinoid cycle pathway in Stra6−/− mice

PCA revealed VAD Stra6−/− samples were separated from not only WT but also VAS Stra6−/− samples (Fig. 2C). This accounted for the 86% variance in the first principal component (PC1). We identified DE genes in the VAD Stra6−/− and WT samples relative to the respective VAS samples. Analyses, using a false discovery rate (FDR) cutoff at 0.05, uncovered 482 genes in VAD WT and 8,387 in VAD Stra6−/− groups (Fig. 4A). Based on the two analyses, there was an overlap of 1,742 genes in this comparison.

Fig. 4.

Fig. 4.

Comparison between Stra6−/− and WT mice on a VAD diet. Venn diagram representing the overlap of differentially expressed genes between WT and Stra6−/− VAD samples (A). Volcano plot of significant genes (B). Enriched pathways (C) and GO BP ontology terms from the down-regulated (D) genes comparing Stra6−/− VAD relative to WT VAD samples. n = 5 mice per group. Cldn3, claudin 3; Cldn4, claudin 4; Dsc2, desmocollin 2; Dsc3, desmocollin 3; Lrat, lecithin–retinol acyltransferase; Pkp1, plakophilin 1; Rdh5, retinol dehydrogenase 5; Rbp1, retinol-binding protein 1, cellular; Rpe65, retinal pigment epithelium 65; Tjp1, tight junction protein 1.

We next performed DE and pathway analyses for VAD Stra6−/− relative to VAD WT (Fig. 4B–D). For the highly expressed transcripts, we found that the most significantly enriched pathways include the canonical retinoid cycle in rods and retinol metabolism (fold enrichment = 16.4) (Fig. 4C). The genes associated with these pathways are retinol dehydrogenases (Rdh5 and Rdh10), retinoid-binding proteins (Rbp1 and Rlbp1), lecithin retinol acyltransferase (Lrat), and retinoid isomerase (Rpe65). This suggested that severe VAD results in a transcriptional up-regulation of retinoid cycle genes or a selective stabilization of their transcripts.

Consequences of VAD on structure of the outer BRB

The top biological processes (BP) that are enriched in VAD Stra6−/− compared with VAD WT include epithelium development, cell adhesion, and cell–cell junction organization (fold enrichment = 2) (Fig. 4D). The genes that are down-regulated in these processes are claudins (Cldn3 and Cldn4), plakophilin-1 (Pkp1), and desmocollins (Dsc2 and Dsc3). These different classes encode cell junction proteins in the RPE (Fig. 4B). The desmocollins are cadherins which, together with plakophilins, reside within desmosomal plaques at the basolateral side of the epithelium (35). Claudin proteins make up part of the tight junctions which confer selective barrier function of the oBRB. The effect of the diet on the Stra6 genotype, as seen by differential analysis between VAD and VAS Stra6−/−, reiterates the effect on cell adhesion (Fig. S4A). The significantly down-regulated Tjp1 gene encodes one of the major RPE tight junction proteins zonula occludens (ZO)-1. ZO-1, together with occludins, contributes to forming an intact barrier and is integral for preserving RPE polarity (35). These results collectively suggest that vitamin A restriction significantly affects the structural integrity of the oBRB.

In accordance with the ocular retinoids (Fig. 1B and C), retina morphology (Figs. 3F and S2), and electroretinography (ERG) responses (Fig. S3), we did not note considerable changes in the VAD WT group. However, of the gene set, transcript levels of Thbs4 which encodes the extracellular matrix (ECM) protein Thrombospondin-4 (TSP-4) were significantly higher. Elevated TSP-4 protein expression in injured tissues has been associated with mechanisms of ECM remodeling (36). Similarly, the ECM organization pathway (fold enrichment = 2.6) was significantly enriched in VAD Stra6−/− (Fig. S4B). Comp and Mmp12, encoding additional ECM remodeling proteins, transcripts were abundant, implying alterations in the structural support between the RPE, Bruch's membrane, and choroid.

Severe VAD disrupted oBRB maintenance and permeability

The modest elevated RPE65 protein expression in RPE tissue from mice on a VAD diet (Figs. 5A and B and S5) correlates with the enrichment of the retinoid cycle pathway in VAD Stra6−/− samples (Figs. 4C and S4B). Quantitative PCR results further supported the increase in visual cycle gene expression (Fig. 5C) as well as the decrease in expression of genes encoding cellular junction proteins. Epithelial marker E-cadherin Cdh1 and desmosomal cadherin Dsc2 were down-regulated in Stra6−/− compared with WT (Fig. 5D). Intercellular adhesion proteins serve to preserve tissue integrity and RPE structure, and therefore, we prepared whole RPE flatmounts stained with ZO-1 to assess overall morphology. RPE tissue consists of a distinct single layer of cells that are hexagonally packed, as illustrated in the WT VAS and VAD groups (Fig. 6A and B). However, anomalies were predominantly detected in STRA6-deficient RPE tissues. Under the VAS conditions, a few epithelial cells no longer conformed to this pattern, whereas considerable variability in cell shape and size occurred with VAD (Fig. 6C and D).

Fig. 5.

Fig. 5.

Validation by western blot and qPCR. The protein levels of RPE65 were assessed by western blot analysis (A). The loading control β-actin was used for normalization, and the corresponding expression was quantified relative to WT genotype (B). RPE–choroid tissue from four mice (n = 4) were isolated, and each lane represents a unique pool from two mice. The RPE expresses visual cycle genes Lrat and Rdh5 which have been quantified by PCR (C). Relative quantification of mRNA for Cdh1 and Dsc2 which encode for intercellular junction proteins (D). Cdh1, cadherin 1; Dsc2, desmocollin 2; Lrat, lecithin–retinol acyltransferase; Rdh5, retinol dehydrogenase 5; Rpe65, retinal pigment epithelium 65. Values presented as mean ± SD. *P < 0.05 between genotypes, within diet.

Fig. 6.

Fig. 6.

Examining oBRB morphology and barrier function. RPE flatmounts were prepared and stained for ZO-1 (A–D). The adjacent panels for each group marked by (’) represent an independent mouse RPE biological replicate. Scheme of FITC–dextran injections to assess permeability (E). Fluorescence was measured in retina tissue using a spectrophotometer (F). Sham control (phosphate buffered saline [PBS] alone) was used to subtract background autofluorescence. Arrow symbols indicate irregularities in RPE cell morphology. Values presented as mean ± SD. #P < 0.05 between diets, within genotype.

Considering this shift in genes associated to the structural makeup of the oBRB, we investigated whether the transcriptional changes translated to a loss of barrier function. To evaluate if the oBRB has the capacity to properly filter macromolecules, we tested permeability of 10 kDa fluorescein isothiocyanate (FITC)–dextran (Fig. 6E). FITC–dextran was injected i.p. to WT and Stra6−/− mice 12 weeks after the dietary intervention, and eye samples were collected. To ensure we were accounting for FITC–dextran which crossed the barrier rather than that which may be adhering to the exterior surface of the eye, fluorescence was measured from isolated retina tissue. As shown in Fig. 6F, the relative fluorescence in VAD WT mice was slightly higher, albeit not significant, compared with VAS WT mice. However, the significantly elevated fluorescence intensity of the Stra6−/− VAD group suggested increased permeability and a compromised oBRB.

Up-regulation of transporters in the solute carrier superfamily and ATPase subunits

One of the barrier functions is to control the exchange of solutes and nutrients between the circulation and the retina. There was an enrichment in the ion and transmembrane transport terms (fold enrichment = 3.5). The transcripts for numerous genes encoding transporters belonging to the SLC were elevated in Stra6−/− VAD samples (Fig. S6). Slc2a1 encodes glucose transporter 1 (GLUT1) which transports glucose to the retina where it is utilized as an energy source. Slc6a genes encode for the creatine transporter (CRT) protein for uptake of creatine needed to maintain ATP levels in the retina (37). Interestingly, the Atp1b1 gene, encoding the β subunit of the Na,K-ATPase, was also elevated. Previous studies suggest that Na,K-ATPase activity is involved in the structure of tight junctions. Alterations in the permeability and ion homeostasis have been shown to affect the levels of Na,K-ATPase expression at either the apical or basolateral side of the RPE (38). Taken together, these results strengthen the observed link between VAD and a loss of oBRB function which may result in retinal degeneration.

Discussion

VAD is a serious public health concern, and an estimated 200 million children are at risk of VAD disorders (22, 39–41). The eyes are particularly vulnerable to this ailment (42). In its milder form, ocular VAD causes reversible night blindness. Clinically, the deficiency manifests as xerophthalmia with conjunctival xerosis and Bitot spots and eventually leads to corneal xerosis, corneal ulceration, keratomalacia, and retinal dystrophies (22, 42). While the significance of VAD for the front of the eyes is well defined, the pathological consequences for the back of the eyes are less well studied (43).

More than 60 years ago, Dowling and Wald described the consequences of VAD in rat retina (23). Initially, the depletion of liver stores of the vitamin A led to a decrease in blood ROL levels. In the retina, rod visual pigment (Rho) declined first before the opsin protein vanished in photoreceptors. The decline of Rho was mirrored in abnormal ERG responses and histological alteration of the retina (23). Since mice only develop ocular VAD when subjected to months of dietary intervention with vitamin A-free diet (27), follow-up studies were conducted in Rpe65−/− mice (44). These chromophore-deficient mice displayed activation of sensory transduction by unliganded opsin and slow degeneration of rods (45, 46), whereas cone photoreceptors died rapidly (47). It has been previously reported that this condition differs from nutritional VAD in mice (27). In fact, severe VAD is associated with irreversible retina degeneration (48). To better understand the pathology, we herein investigated adaptive responses to vitamin A deprivation. We identified impacted pathways in an unbiased approach from the RPE–choroid tissue, which separates the retina from the choroidal circulation. The photoreceptor layer is avascular, and therefore, nutrients from the choroid are provided through the RPE layer (49, 50). We developed a method to simulate mild and severe deficient states in mice. RNA-seq analyses have revealed effects not only in the retinoid cycle and phototransduction cascade but also epithelia structural maintenance. These findings are consistent with two essential roles of the RPE–choroid layers, production of 11-cis-retinal and oBRB function (51–55).

What is the consequence of restricting vitamin A in the diet? The eyes maintain critical processes using mechanisms established to avoid vulnerability to vitamin A status (1). Total ocular retinoid levels were unaffected in WT mice but significantly reduced when STRA6, integral to the homeostatic system, is not expressed. Stra6−/− mice on the VAS diet experienced a ~75% decrease, while those on a VAD diet possessed trace amounts in the ocular tissue (Fig. 1B and C). Neither preformed vitamin A carried by chylomicrons nor retinol diffusing passively can fully substitute for STRA6-mediated uptake. Both mild and severe deficiency resulted in a decrease of scotopic and photopic vision (Figs. 3A and S3). This was accompanied by a significant down-regulation of genes encoding proteins orchestrating cone phototransduction (Fig. 2D). In a chromophore-deprived photoreceptor, cone opsins are mistrafficked and cone-specific proteins such as PDE6 protein levels are reduced (47, 56). Moreover, ligand binding improves opsin stability and pigment trafficking to cone outer segments. Rods outnumber cones in the retina, so competition for limited chromophore is unfavorable for cones (57). Thus, mild VAD shows many characteristics described in chromophore-deficient mouse eyes.

RPE cells are joined together by tight and adherens junctions near the apical microvilli as well as desmosomes close to the basolateral membrane (52, 58, 59). Optimal ion and nutrient homeostasis in the subretinal space are necessary for preserving photoreceptor excitability and overall retinal health (60–62). A compromised oBRB triggers retinal degeneration, and retinoid signaling is required for development of this structure (35, 63). However, the relationship between vitamin A status and the oBRB has not been well established. Stra6−/− mice exhibiting severe VAD showed a down-regulation of transcripts of genes encoding proteins that span all three junctions (Fig. 4). Epithelial and endothelial cell layers have tight junctions generating selective barriers that enable tissue-specific activity as seen in the skin, intestine, brain, and eye (64, 65). RA is a vitamin A metabolite whose signaling has been implicated in the maintenance of tissue–blood barriers by altering expression of tight junction proteins (63, 66, 67). The BRB is analogous to the blood–brain barrier (BBB), and the importance of RA signaling has been emphasized during the developmental stages. Interestingly, prior research has demonstrated RA induces BBB genes such as tight junction proteins ZO-1 and cadherins (68). The exact influence of RA on the BBB and a variety of epithelia is inconclusive, as in vitro and in vivo testing has presented results showing both positive and negative RA effects (69–72).

The BRB consists of both outer and inner components, and the integrity of the inner BRB, lining the retinal vasculature, is vulnerable to reduced RA signaling (63). A similar phenomenon was supported in our studies of the oBRB. Phenotypically, RPE from WT mice followed a repetitive, hexagonal shape. In contrast, the RPE cells varied in shape and size in Stra6−/− mice on a VAD diet. A loss of structural integrity translated to increased permeability to macromolecules (FITC–dextran) (Fig. 6). Our gene set indicated a down-regulation of genes encoding alcohol and aldehyde dehydrogenases involved in RA metabolism. The role of vitamin A in maintaining the oBRB is novel and has implications beyond the physical integrity of the ocular tissue. Tight junctions are multiprotein complexes constituting of transmembrane, peripheral, and cytoplasmic proteins. Many proteins associated with tight junctions act as adaptors to stabilize junctions or scaffolds to recruit proteins for intracellular signaling. Additionally, tight junctions demarcate boundaries between the apical and basolateral membranes, and the polarized distribution of transporters and channels is important for supporting the adjacent photoreceptors (73–75).

Together, our study revealed that ocular consequences of nutritional VAD are attributed to not only chromophore deficiency but also compromised retinoid signaling in the RPE. Damage to the RPE causes other retinal diseases such as age-related macular degeneration (76). How retinoid homeostasis conferred by STRA6 or oBRB transcriptional alterations is associated to the pathophysiology of such diseases warrants further investigations. A better understanding of the role of vitamin A at the oBRB will aid in the development of intervention strategies for children suffering from severe VAD eventually leading to retinal degeneration and vision loss as well as for other blinding diseases.

Materials and methods

Animal care and use

The use of mice in this study was approved by the Case Western Reserve University (CWRU) Institutional Animal Care and Use Committee. Stra6−/− mice on a C57BL/6J genetic background were generated in the vivarium at CWRU as previously described. WT mice were obtained from the Jackson Laboratory. All mice were bred and raised on a standard chow diet containing ∼15,000 IU vitamin A/kg diet (Prolab RMH 3000, LabDiet, St. Louis, MO, USA) with ad libitum access to food and water on a 12:12 h light/dark cycle. After weaning, mice were supplemented with a VAS (4,000 IU vitamin A, retinyl acetate) or VAD (0 IU vitamin A) diet. All mice were maintained on either diet for 12 weeks which is an established timepoint when vitamin A stores are depleted in mice (21). The diets were prepared by Research Diets (New Brunswick, NJ, USA). At the end of the dietary intervention, mice were anesthetized by using a ketamine (60 mg/kg) and xylazine (5 mg/kg) cocktail. Mice were transcardially perfused with PBS and sacrificed by cervical dislocation. Tissues were immediately harvested for analysis or snap frozen in liquid nitrogen and stored at −80°C until further use (77,78).

HPLC retinoid analysis

Preparation and analyses of retinoid concentrations were performed as previously described (20, 21, 77, 78). For the liver, 10 mg of tissue was homogenized in 200 μL PBS. One entire eyecup was homogenized in 200 μL hydroxylamine (2 m, pH 6.8). Retinoids were extracted twice using a mixture of 200 μL methanol, 400 μL acetone, and 500 µL hexane added to the tissue homogenates. A normal-phase Zorbax SIL (5 μm, 4.6 × 150 mm) column was used for HPLC analysis. Chromatographic separation was achieved by isocratic flow of 10% ethyl acetate/90% hexanes. To quantify the molar amounts of retinoids, the HPLC was previously calibrated with synthetic standard compounds.

RPE eyecup isolation and RNA extraction

Eyes were enucleated, and muscle and connective tissue were removed, followed by the removal of the anterior segment and vitreous. The eyecup was incubated with 2% dispase for 15 min in 37°C. The neural retina was carefully peeled off while limiting the extent of disturbing the RPE layer, and the remaining RPE–choroid tissue was rinsed with PBS. The RPE–choroid tissues from two eyecups were pooled together for RNA isolation. Tissue was immediately homogenized in 500 μL of TRIzol, 100 μL of chloroform was added, and the samples were centrifuged at 12,000 × g for 15 min at 4°C. The aqueous phase was collected, and 500 μL of 70% ethanol was added. This mixture was added directly to a RNeasy mini column (Qiagen). RNA extraction was completed using the RNeasy Plus Mini Kit.

cDNA library preparation and RNA sequencing

Quantitation and sample integrity and purity were tested using the Nanodrop and Agilent 2100 for quality control. Only samples with A260/A280 ratios >1.8–2 were submitted for further processing at Novogene Genomics Technology. For library construction, mRNA was enriched using oligo(dT) beads, fragmented randomly, and then cDNA was synthesized using random hexamer primers, dNTPs, RNase H, and DNA polymerase I. Following terminal repair, A ligation, and sequencing adaptor ligation, the double-stranded cDNA library was completed through size selection and PCR enrichment. The Illumina NovaSeq platform was used to sequence samples using paired-end sequencing (2 × 150 bp). The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession number GSE219252 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE219252) (28).

Mapping, gene-level analysis, and GO analysis

The samples have an average 26.2 million 150 bp long paired-end reads. Fastqc (version 0.11.2) was used for sequencing quality assessment. Multiqc (version 1.5) was used to aggregate results into a single report. Reads were then aligned to GRCm38/mm10 genome (UCSC genome source, 2011) using STAR (version 2.5.3a). An average of 87.4% of reads was uniquely mapped to the reference genome. The correlated annotation file (GTF) was applied and the gene expression level was determined by RSEM (version 1.2.30) quantification. Lowly expressed genes (counts less than five) were filtered. From the 18,691 remaining genes, analysis was carried out using DESeq2, which normalizes for sequencing depth differences (79). We were investigating how diet and the Stra6 mutation influence gene expression, and we opted in using a multifactor design. VAS and WT were set as the reference levels for comparisons. Significant genes were determined by the adjusted P < 0.05. The threshold was set to include all genes with a log2 fold change >|2|. GO analysis, enrichment of BP terms, and pathway analysis were performed using the g:GOSt tool from g:Profiler (80, 81). Overrepresentation of these processes was assessed by fold enrichment that was computed by comparing the relative frequency of input genes in the samples to the frequency of genes annotated to the term or pathway in the background (universe).

qRT-PCR

Total RNA was extracted from RPE eyecups using the TRIzol method (Invitrogen, Carlsbad, CA). The Nano drop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) was used to quantify RNA, and cDNA was generated using the High Capacity RNA to cDNA kit (Applied Biosystems, Thermo Fisher Scientific). RT-PCR was carried out using the TaqMan Master Mix (Applied Biosystems, Thermo Fisher Scientific) and the primers (Applied Biosystems) to amplify β-actin (Mm02619580), Cdh1 (Mm00516355), Dsc2 (Mm00516355), Lrat (Mm00469972), and Rdh5 (Mm07299950). Based on the comparative delta-Ct method, gene expression levels were normalized using the housekeeping gene β-actin.

Immunoblotting

RPE65 protein levels were assessed in the RPE–choroid tissue isolated from the mouse eyes. Tissue samples were homogenized in T-PER Tissue Protein Extraction Reagent (Thermo Scientific) solution with 2 mm phenylmethylsulfonyl fluoride (PMSF). After 30-min incubation on ice, the supernatant was isolated after centrifugation (15 min, 10,000 × g at 4°C) and stored at −80°C until further use. Protein concentrations were determined using the BCA protein assay (Thermo Fisher Scientific). Forty micrograms of protein lysates was mixed with 2X loading buffer (1 m Tris-HCl, pH 6.8, 1 m dithiothreitol (DTT), and 10% sodium dodecyl sulfate [SDS]) and loaded on Sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS–PAGE) gels (12%). The protein was then transferred to polyvinylidene difluoride (PVDF) membranes (Bio-Rad). Membranes were blocked using 5% (w/v) nonfat dry milk dissolved in Tris-buffered saline containing 0.01% Tween-20 for 1 h at room temperature. The blots were washed and incubated overnight at 4°C with the appropriate primary antibody. As a loading control, β-actin antiserum (Cell Signaling, Boston, MA) was used at a dilution of 1:2,000. The antibody to RPE65 (noncommercial) was used to probe the blots. Goat antimouse IgG (Promega, Madison, WI) was employed as a secondary antibody (1:5,000) and incubated for 1 h at room temperature. All antibodies were diluted in Tris-buffered saline containing 0.01% Tween-20. The Odyssey Imaging System (LI-COR Biosciences) was used to scan western blots with chemiluminescence.

Histology

Following PBS perfusion, the eyes were isolated from mice and fixed in 4% paraformaldehyde overnight at room temperature. The Visual Sciences Research Center Histology Core at Case Western Reserve University conducted paraffin embedding, retinal sectioning (10 μm), and hematoxylin and eosin (HE) staining. The HE-stained sections were imaged using the Leica DM600 microscope (77).

The RPE flatmount and immunostaining

Following euthanasia, the eyes were immediately harvested and fixed with 4% paraformaldehyde for 1 h. The cornea, lens, and vitreous were removed, and radial incisions were made to flatten the remaining eyecup. The RPE layer was separated from the retinal tissue. The RPE flatmounts were incubated with 0.5% Triton X-100 in PBS (30 min) for permeabilization and then with ZO-1 polyclonal primary antibody (1:100; Thermo Fisher Scientific, 61-7300) overnight at 4°C. The flatmounts were washed with PBST (0.1% Triton X-100 in PBS). Alexa Fluor 488 was used as the secondary antibody (1:500; 2 h room temperature). The flatmounts were washed with PBST and then PBS before mounting on microscope slides. Images were acquired using the Leica Hyvolution SP8 confocal microscope. The argon laser (excitation 488 nm) was used with a ×63 C-Apochromat, NA, 1.4-O objective.

Spectral domain OCT and SLO imaging

One percent tropicamide (Bausch and Lomb, Tampa, FL) eye drops were applied to dilate the pupils prior to the eye examination. Mice were anesthetized intraperitoneally with a ketamine/xylazine rodent cocktail. The optic nerve was positioned in the center before acquiring spectral domain OCT (SD-OCT, Bioptigen) images. B-scan images were acquired and averaged using the Bioptigen software (20). Retinal changes between treatment groups were assessed by measuring the thickness of the outer retina layers (including photoreceptor outer nuclear layer and inner/outer segments) 0.25–0.75 mm from the optic nerve head. The thickness values were averaged from retinas of four mice in each experimental group. Mouse fundus images were collected using the confocal SLO (SLO Spectralis HRA2, Heidelberg Engineering, Heidelberg, Germany). To obtain evenly illuminated fundus images, the fundus camera was aligned to the pupil using the near-infrared reflective laser (820 nm) (20, 77).

Electroretinography

Mice were dark adapted overnight prior to examination. One percent tropicamide (Bausch and Lomb, Tampa, FL) was used to dilate the pupils, and mice were anesthetized using a ketamine/xylazine rodent cocktail. Mice were placed on a heating pad throughout the recording session to keep the body temperature at 37°C. Ag–AgCl electrodes were placed on the surface of the cornea (Diagnosys Celeris, Lowell, MA). For dark-adapted ERG responses, mice were exposed to 10 steps of a white light, flash stimulus ranging from 0.001 to 20 cd s × m−2. Interstimulus intervals were set at 4 s for low-luminance flashes and 90 s for the highest stimulus. For cone ERG responses, mice were exposed to a steady adapting light field for 7 min, and waveforms were recorded with strobe-flash stimuli (0.32 to 63 cd s × m−2) superimposed on the adapting field. Amplitude values were averaged between left and right eyes (20, 77).

FITC–dextran injections

The permeability of the oBRB was assessed using a method adapted from an assay measuring BBB permeability (82). After Stra6−/− and WT mice were supplemented with either a VAS or VAD diet, three mice were injected intraperitoneally with 10 and 40 kDa FITC–dextran or PBS (sham). After 5 min, the mice were injected with ketamine–xylazine. The mice were perfused with PBS. The eyes were then immediately enucleated, and the retina tissue layer was pooled from each mouse for further processing. The tissue was homogenized in cold PBS, centrifuged at 10,000 × g for 20 min at 4°C, and the supernatant was transferred to a new tube. Fluorescence was measured in retina tissue supernatants using the FlexStation 3 Multi-Mode Microplate Reader (Molecular Devices). Fluorescence measurements acquired from the sham control group were used to account for autofluorescence and to subtract background. To avoid photobleaching, the samples were shielded from light at all stages.

Statistical analysis

Unpaired t test was used when comparing values between genotype (WT vs. Stra6−/−) for ERG results. Two-way ANOVA was used when the observed effect is influenced by both variables, diet and genotype. The Tukey method was carried out for post hoc multiple comparisons. An alpha level of P < 0.05 was considered significant.

Supplementary Material

pgad167_Supplementary_Data

Acknowledgments

We thank the Case Western Center for RNA Science and Therapeutics for their guidance and advice with data processing and analysis. All original animations are created with BioRender.com.

Contributor Information

Jean Moon, Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

Gao Zhou, Center for RNA Science and Therapeutics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

Eckhard Jankowsky, Center for RNA Science and Therapeutics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

Johannes von Lintig, Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

Supplementary material

Supplementary material is available at PNAS Nexus online.

Funding

This work was funded by the National Eye Institute (EY028121 and EY011373) and the T32 Visual Science Training Grant (EY007157).

Author contributions

J.M. and J.v.L. designed the research; J.M. performed the research; J.M., G.Z., E.J., and J.v.L. analyzed the data; and J.M. and J.v.L. wrote the manuscript.

Data availability

The data that support findings in this publication are available in NCBI’s Gene Expression Omnibus (28) and are accessible through GEO Series accession number GSE219252 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE219252).

References

  • 1. von Lintig J, Moon J, Babino D. 2021. Molecular components affecting ocular carotenoid and retinoid homeostasis. Prog Retin Eye Res. 80:100864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Yau KW, Hardie RC. 2009. Phototransduction motifs and variations. Cell 139:246–264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940–954. [PubMed] [Google Scholar]
  • 4. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. 2001. Nuclear receptors and lipid physiology: opening the X-files. Science 294:1866–1870. [DOI] [PubMed] [Google Scholar]
  • 5. Duester G. 2022. Towards a better vision of retinoic acid signaling during eye development. Cells 11:322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Blaner WS, et al. 2016. Vitamin A absorption, storage and mobilization. Subcell Biochem. 81:95–125. [DOI] [PubMed] [Google Scholar]
  • 7. Blaner WS, et al. 1994. Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J Biol Chem. 269:16559–16565. [PubMed] [Google Scholar]
  • 8. Kawaguchi R, et al. 2007. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315:820–825. [DOI] [PubMed] [Google Scholar]
  • 9. Bok D, Heller J. 1976. Transport of retinol from the blood to the retina: an autoradiographic study of the pigment epithelial cell surface receptor for plasma retinol-binding protein. Exp Eye Res. 22:395–402. [DOI] [PubMed] [Google Scholar]
  • 10. Sun H. 2012. Membrane receptors and transporters involved in the function and transport of vitamin A and its derivatives. Biochim Biophys Acta. 1821:99–112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kelly M, von Lintig J. 2015. STRA6: role in cellular retinol uptake and efflux. Hepatobiliary Surg Nutr. 4:229–242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Isken A, et al. 2008. RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for Matthew-Wood syndrome. Cell Metab. 7:258–268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Zhong M, et al. 2020. Regulatory mechanism for the transmembrane receptor that mediates bidirectional vitamin A transport. Proc Natl Acad Sci U S A. 117:9857–9864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Chassaing N, et al. 2009. Phenotypic spectrum of STRA6 mutations: from Matthew-Wood syndrome to non-lethal anophthalmia. Hum Mutat. 30:E673–E681. [DOI] [PubMed] [Google Scholar]
  • 15. Pasutto F, et al. 2007. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet. 80:550–560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Golzio C, et al. 2007. Matthew-Wood syndrome is caused by truncating mutations in the retinol-binding protein receptor gene STRA6. Am J Hum Genet. 80:1179–1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Clagett-Dame M, DeLuca HF. 2002. The role of vitamin A in mammalian reproduction and embryonic development. Annu Rev Nutr. 22:347–381. [DOI] [PubMed] [Google Scholar]
  • 18. Ruiz A, et al. 2012. Retinoid content, visual responses, and ocular morphology are compromised in the retinas of mice lacking the retinol-binding protein receptor, STRA6. Invest Ophthalmol Vis Sci. 53:3027–3039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Amengual J, et al. 2014. STRA6 is critical for cellular vitamin A uptake and homeostasis. Hum Mol Genet. 23:5402–5417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Ramkumar S, et al. 2022. The vitamin A transporter STRA6 adjusts the stoichiometry of chromophore and opsins in visual pigment synthesis and recycling. Hum Mol Genet. 31:548–560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Kelly M, Widjaja-Adhi MA, Palczewski G, von Lintig J. 2016. Transport of vitamin A across blood-tissue barriers is facilitated by STRA6. FASEB J. 30:2985–2995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Sommer A, Vyas KS. 2012. A global clinical view on vitamin A and carotenoids. Am J Clin Nutr. 96:1204S–1206S. [DOI] [PubMed] [Google Scholar]
  • 23. Dowling JE, Wald G. 1958. Vitamin a deficiency and night blindness. Proc Natl Acad Sci U S A. 44:648–661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Dowling JE, Wald G. 1960. The biological function of vitamin A acid. Proc Natl Acad Sci U S A. 46:587–608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Samardzija M, et al. 2008. R91w mutation in Rpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinal. Hum Mol Genet. 17:281–292. [DOI] [PubMed] [Google Scholar]
  • 26. Maeda T, Maeda A, Leahy P, Saperstein DA, Palczewski K. 2009. Effects of long-term administration of 9-cis-retinyl acetate on visual function in mice. Invest Ophthalmol Vis Sci. 50:322–333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Hu Y, et al. 2011. Comparison of ocular pathologies in vitamin A-deficient mice and RPE65 gene knockout mice. Invest Ophthalmol Vis Sci. 52:5507–5514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. [dataset] von Lintig J, Moon J, Jankowsky E, Zhou G. Bulk RNA-seq of eyes isolated from wildtype and Stra6 knockout mice maintained on either a vitamin A sufficient or deficient diet.
  • 29. Ross AC. 2010. Diet in vitamin A research. Methods Mol Biol. 652:295–313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Obrochta KM, Kane MA, Napoli JL. 2014. Effects of diet and strain on mouse serum and tissue retinoid concentrations. PLoS One 9:e99435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Maeda A, Maeda T, Golczak M, Palczewski K. 2008. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J Biol Chem. 283:26684–26693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Chen Y, et al. 2013. Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. J Clin Invest. 123:5119–5134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Makabe K, Sugita S, Mandai M, Futatsugi Y, Takahashi M. 2020. Microglia dynamics in retinitis pigmentosa model: formation of fundus whitening and autofluorescence as an indicator of activity of retinal degeneration. Sci Rep. 10:14700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Qin Y, et al. 2022. ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization. JCI Insight 7:e157896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Fields MA, Del Priore LV, Adelman RA, Rizzolo LJ. 2020. Interactions of the choroid, Bruch’s membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier. Prog Retin Eye Res. 76:100803. [DOI] [PubMed] [Google Scholar]
  • 36. Kim DJ, Christofidou ED, Keene DR, Hassan Milde M, Adams JC. 2015. Intermolecular interactions of thrombospondins drive their accumulation in extracellular matrix. Mol Biol Cell. 26:2640–2654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Dahlin A, et al. 2013. Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures. Mol Pharm. 10:650–663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Rajasekaran SA, et al. 2003. Na,K-ATPase inhibition alters tight junction structure and permeability in human retinal pigment epithelial cells. Am J Physiol Cell Physiol. 284:C1497–C1507. [DOI] [PubMed] [Google Scholar]
  • 39. Underwood BA. 2004. Vitamin A deficiency disorders: international efforts to control a preventable “pox”. J Nutr. 134:231S–236S. [DOI] [PubMed] [Google Scholar]
  • 40. Sommer A. 1997. Vitamin A deficiency, child health, and survival. Nutrition 13:484–485. [DOI] [PubMed] [Google Scholar]
  • 41. Sommer A. 2008. Vitamin a deficiency and clinical disease: an historical overview. J Nutr. 138:1835–1839. [DOI] [PubMed] [Google Scholar]
  • 42. Sommer A, Tarwotjo I, Hussaini G, Susanto D, Soegiharto T. 1981. Incidence, prevalence, and scale of blinding malnutrition. Lancet 1:1407–1408. [DOI] [PubMed] [Google Scholar]
  • 43. Tanumihardjo SA. 2011. Vitamin A: biomarkers of nutrition for development. Am J Clin Nutr. 94:658S–665S. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Redmond TM, et al. 1998. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 20:344–351. [DOI] [PubMed] [Google Scholar]
  • 45. Fan J, Woodruff ML, Cilluffo MC, Crouch RK, Fain GL. 2005. Opsin activation of transduction in the rods of dark-reared Rpe65 knockout mice. J Physiol. 568:83–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Woodruff ML, et al. 2003. Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Nat Genet. 35:158–164. [DOI] [PubMed] [Google Scholar]
  • 47. Rohrer B, et al. 2005. Cone opsin mislocalization in Rpe65-/- mice: a defect that can be corrected by 11-cis retinal. Invest Ophthalmol Vis Sci. 46:3876–3882. [DOI] [PubMed] [Google Scholar]
  • 48. Lamb TD, Pugh EN Jr. 2004. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 23:307–380. [DOI] [PubMed] [Google Scholar]
  • 49. Onishi AC, Fawzi AA. 2019. An overview of optical coherence tomography angiography and the posterior pole. Ther Adv Ophthalmol. 11:2515841419840249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Campbell JP, et al. 2017. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep. 7:42201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Strauss O. 2005. The retinal pigment epithelium in visual function. Physiol Rev. 85:845–881. [DOI] [PubMed] [Google Scholar]
  • 52. Rizzolo LJ, Peng S, Luo Y, Xiao W. 2011. Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium. Prog Retin Eye Res. 30:296–323. [DOI] [PubMed] [Google Scholar]
  • 53. Yang S, Zhou J, Li D. 2021. Functions and diseases of the retinal pigment epithelium. Front Pharmacol. 12:727870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Sparrow JR, Hicks D, Hamel CP. 2010. The retinal pigment epithelium in health and disease. Curr Mol Med. 10:802–823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Lakkaraju A, et al. 2020. The cell biology of the retinal pigment epithelium. Prog Retin Eye Res. 78:100846. 10.1016/j.preteyeres.2020.100846 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Zhang H, et al. 2008. Trafficking of membrane-associated proteins to cone photoreceptor outer segments requires the chromophore 11-cis-retinal. J Neurosci. 28:4008–4014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Samardzija M, et al. 2009. In conditions of limited chromophore supply rods entrap 11-cis-retinal leading to loss of cone function and cell death. Hum Mol Genet. 18:1266–1275. [DOI] [PubMed] [Google Scholar]
  • 58. Hudspeth AJ, Yee AG. 1973. The intercellular junctional complexes of retinal pigment epithelia. Invest Ophthalmol. 12:354–365. [PubMed] [Google Scholar]
  • 59. Rizzolo LJ. 2007. Development and role of tight junctions in the retinal pigment epithelium. Int Rev Cytol. 258:195–234. [DOI] [PubMed] [Google Scholar]
  • 60. Steinberg RH. 1985. Interactions between the retinal pigment epithelium and the neural retina. Doc Ophthalmol. 60:327–346. [DOI] [PubMed] [Google Scholar]
  • 61. Wimmers S, Karl MO, Strauss O. 2007. Ion channels in the RPE. Prog Retin Eye Res. 26:263–301. [DOI] [PubMed] [Google Scholar]
  • 62. Reichhart N, Strauß O. 2014. Ion channels and transporters of the retinal pigment epithelium. Exp Eye Res. 126:27–37. [DOI] [PubMed] [Google Scholar]
  • 63. Pollock LM, Xie J, Bell BA, Anand-Apte B. 2018. Retinoic acid signaling is essential for maintenance of the blood-retinal barrier. FASEB J. 32:5674–5684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Anderson JM, Van Itallie CM. 2009. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 1:a002584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Marchiando AM, Graham WV, Turner JR. 2010. Epithelial barriers in homeostasis and disease. Annu Rev Pathol. 5:119–144. [DOI] [PubMed] [Google Scholar]
  • 66. Li J, Li Q, Geng S. 2019. Alltrans retinoic acid alters the expression of the tight junction proteins Claudin1 and 4 and epidermal barrier function-associated genes in the epidermis. Int J Mol Med. 43:1789–1805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Engelbrecht E, Metzler MA, Sandell LL. 2022. Retinoid signaling regulates angiogenesis and blood-retinal barrier integrity in neonatal mouse retina. Microcirculation 29:e12752. [DOI] [PubMed] [Google Scholar]
  • 68. Mizee MR, et al. 2013. Retinoic acid induces blood-brain barrier development. J Neurosci. 33:1660–1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Baltes S, Nau H, Lampen A. 2004. All-trans retinoic acid enhances differentiation and influences permeability of intestinal Caco-2 cells under serum-free conditions. Dev Growth Differ. 46:503–514. [DOI] [PubMed] [Google Scholar]
  • 70. Osanai M, et al. 2007. Cellular retinoic acid bioavailability determines epithelial integrity: role of retinoic acid receptor alpha agonists in colitis. Mol Pharmacol. 71:250–258. [DOI] [PubMed] [Google Scholar]
  • 71. Ortiz-Melo MT, et al. 2013. Expression of claudins −2 and −4 and cingulin is coordinated with the start of stratification and differentiation in corneal epithelial cells: retinoic acid reversibly disrupts epithelial barrier. Biol Open. 2:132–143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Bonney S, Siegenthaler JA. 2017. Differential effects of retinoic acid concentrations in regulating blood-brain barrier properties. eNeuro 4:ENEURO.0378-16.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Cereijido M, Valdés J, Shoshani L, Contreras RG. 1998. Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol. 60:161–177. [DOI] [PubMed] [Google Scholar]
  • 74. Schneeberger EE, Lynch RD. 2004. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 286:C1213–C1228. [DOI] [PubMed] [Google Scholar]
  • 75. Shin K, Fogg VC, Margolis B. 2006. Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 22:207–235. [DOI] [PubMed] [Google Scholar]
  • 76. Ambati J, Fowler BJ. 2012. Mechanisms of age-related macular degeneration. Neuron 75:26–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Moon J, Ramkumar S, von Lintig J. 2023. Genetic tuning of β-carotene oxygenase-1 activity rescues cone photoreceptor function in STRA6-deficient mice. Hum Mol Genet. 32:798–809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Moon J, Ramkumar S, von Lintig J. 2022. Genetic dissection in mice reveals a dynamic crosstalk between the delivery pathways of vitamin A. J Lipid Res. 63:100215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Raudvere U, et al. 2019. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47:W191–W198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Kolberg L, Raudvere U, Kuzmin I, Vilo J, Peterson H. 2020. gprofiler2—an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler. F1000Res. 9:709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Devraj K, Guérit S, Macas J, Reiss Y. 2018. An in vivo blood-brain barrier permeability assay in mice using fluorescently labeled tracers. J Vis Exp. 132:57038. doi: 10.3791/57038 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

pgad167_Supplementary_Data

Data Availability Statement

The data that support findings in this publication are available in NCBI’s Gene Expression Omnibus (28) and are accessible through GEO Series accession number GSE219252 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE219252).


Articles from PNAS Nexus are provided here courtesy of Oxford University Press

RESOURCES